SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Enfuse Solutions Ltd

Industry : Computers - Software - Medium / Small

BSE Code

ISIN Demat

Book Value()

92697

INE0S3X01014

22.1727926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ENFUSE

146.03

EPS(TTM)

Face Value()

Div & Yield %

Back

Eiko Lifesciences consolidated net profit rises 23.81% in the March 2026 quarter

May 26,2026

Net profit of Eiko Lifesciences rose 23.81% to Rs 1.30 crore in the quarter ended March 2026 as against Rs 1.05 crore during the previous quarter ended March 2025. Sales rose 62.73% to Rs 18.34 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 113.27% to Rs 4.50 crore in the year ended March 2026 as against Rs 2.11 crore during the previous year ended March 2025. Sales rose 39.96% to Rs 52.71 crore in the year ended March 2026 as against Rs 37.66 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	18.34	11.27	63	52.71	37.66	40
OPM %	12.32	11.62	-	14.10	7.33	-
PBDT	2.27	1.55	46	8.13	3.46	135
PBT	2.02	1.30	55	7.12	2.72	162
NP	1.30	1.05	24	4.50	2.11	113

78,009.25 -70.71 ( -0.09%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)